Antibody-Based Cancer Immunotherapy - Episode 24
For High-Definition, Click
The success of immunotherapies will change the way clinical trials are conducted and reported, suggests Louis M. Weiner, MD. Additionally, the success of these agents will set the bar higher for future therapies.
In this segment, panelists discuss their thoughts on future immunotherapy strategies, including treatment strategies that incorporate chimeric antigen receptor therapies, tumor infiltrating lymphocytes, and vaccines.
View the video, to hear the discussion.